首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?
【2h】

Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?

机译:肺动脉高压患者血清胎儿腱糖蛋白-C变异水平升高:反映血管重构和右心功能不全的新型生物标志物?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pulmonary vascular remodeling is a pathophysiological feature that common to all classes of pulmonary hypertension (PH) and right ventricular dysfunction, which is the major prognosis-limiting factor. Vascular, as well as cardiac tissue remodeling are associated with a re-expression of fetal variants of cellular adhesion proteins, including tenascin-C (Tn-C). We analyzed circulating levels of the fetal Tn-C splicing variants B+ and C+ Tn-C in serum of PH patients to evaluate their potential as novel biomarkers reflecting vascular remodeling and right ventricular dysfunction. Serum concentrations of B+ and C+ Tn-C were determined in 80 PH patients and were compared to 40 healthy controls by enzyme-linked immunosorbent assay. Clinical, laboratory, echocardiographic, and functional data were correlated with Tn-C levels. Serum concentrations of both Tn-C variants were significantly elevated in patients with PH (p < 0.05). Significant correlations could be observed between Tn-C and echocardiographic parameters, including systolic pulmonary artery pressure (B+ Tn-C: r = 0.31, p < 0.001, C+ Tn-C: r = 0.26, p = 0.006) and right atrial area (B+ Tn-C: r = 0.46, p < 0.001, C+ Tn-C: r = 0.49, p < 0.001), and laboratory values like BNP (B+ Tn-C: r = 0.45, p < 0.001, C+ Tn-C: r = 0.42, p < 0.001). An inverse correlation was observed between Tn-C variants and 6-minute walk distance as a functional parameter (B+ Tn-C: r = −0.54, p < 0.001, C+ Tn-C: r = −0.43, p < 0.001). In a multivariate analysis, B+ Tn-C, but not C+ Tn-C, was found to be an independent predictor of pulmonary hypertension. Both fetal Tn-C variants may represent novel biomarkers that are capable of estimating both pulmonary vascular remodeling and right ventricular load. The potential beneficial impact of Tn-C variants for risk stratification in patients with PH needs further investigation.
机译:肺血管重塑是所有类型的肺动脉高压(PH)和右心室功能障碍所共有的病理生理特征,这是主要的预后限制因素。血管以及心脏组织重塑与细胞粘附蛋白(包括腱糖蛋白-C(Tn-C))的胎儿变异体的重新表达有关。我们分析了PH患者血清中胎儿Tn-C剪接变体B + 和C + Tn-C的循环水平,以评估其作为反映血管重塑和形成的新型生物标志物的潜力。右心功能不全。测定了80名PH患者的血清B + 和C + Tn-C浓度,并通过酶联免疫吸附法将其与40名健康对照者进行了比较。临床,实验室,超声心动图和功能数据与Tn-C水平相关。 PH患者中两种Tn-C变体的血清浓度均显着升高(p <0.05)。 Tn-C与超声心动图参数之间存在显着相关性,包括收缩期肺动脉压(B + Tn-C:r = 0.31,p <0.001,C + Tn -C:r = 0.26,p = 0.006)和右房面积(B + Tn-C:r = 0.46,p <0.001,C + Tn-C: r = 0.49,p <0.001)和实验室值,如BNP(B + Tn-C:r = 0.45,p <0.001,C + Tn-C:r = 0.42,p <0.001)。观察到Tn-C变体与6分钟步行距离之间呈负相关(B + Tn-C:r = -0.54,p <0.001,C + Tn-C:r = −0.43, p <0.001)。在多变量分析中,发现B + Tn-C而非C + Tn-C是肺动脉高压的独立预测因子。两种胎儿Tn-C变体都可以代表新颖的生物标记物,它们能够估计肺血管重构和右心室负荷。 Tn-C变异对PH患者的风险分层的潜在有益影响有待进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号